Trinity Biotech PLC reports results for the quarter ended in June - Earnings Summary

Trinity Biotech

14/08/2024 14:29

* Trinity Biotech PLC  TRIB.OQ  reported a quarterly
adjusted loss
of 71 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -75 cents.  The lone analyst forecast for the quarter was
for a loss of 65 cents per share. 
    * Revenue rose 14% to $15.84 million from a year ago;
analysts
expected $15.75 million. 
    * Trinity Biotech PLC's reported EPS for the quarter was a
loss
of 71 cents​.
    * Trinity Biotech PLC shares had risen by 15.5% this
quarter and
gained 14.7% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * 

This summary was machine generated from LSEG data August 14 at
01:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.65          -0.71          Missed